tobacco cessation in ed utilizing research associates

Tobacco Cessation in ED Utilizing Research Associates

Tobacco Cessation in ED Pilot Study


Using a scripted format, RAs


Using a scripted format, RAs • approached as many ED patients and their visitors

as possible on their weekly 4-hour shift




• obtained verbal assent or written informed consent





• took a detailed tobacco history





• took a detailed tobacco history

• offered a referral to CT Quitline to all who smoked > 30 days at any time in their lives


• 21 weeks, 63 RAs approached 4613 potential participants


• 21 weeks, 63 RAs approached 4613 potential participants4038 (88%) eligible (i.e., no exclusion criteria)


• 21 weeks, 63 RAs approached 4613 potential participants4038 (88%) eligible (i.e., no exclusion criteria)enrolled 3125 participants (78%)



• smoking history (+) → CT Quitline referral




• 54% used tobacco at some time




• 54% used tobacco at some time22% w/i preceding 30 days


• smoked ever = 18% → Quitline referral



• smoked w/i 30 d. = 38% → Quitline referral



• smoked w/i 30 d. = 38% → Quitline referral

• ≈ 50% of all Quitline referralsover those 21 weeks in entire state of CT

Tobacco Cessation in EDValidation Study


• Same study design, except Verbal Assent



• REDCap



• REDCap

• St. Vincent’s +Hartford Hospital and Lawrence & Memorial


• 1 October – 15 December 2010 = beta testing



• Spring, summer and fall semesters 2011= validation study



• Spring, summer and fall semesters 2011= validation study

• 10,000 participants in 30 weeks.

Tobacco Cessation in EDNational Study


• National Alliance of Research Associate Programs (NARAP)



• 15 hospitals (academic and community) around the country




• 2012, 30 weeks → ≈ 70,000 participants




• 2012, 30 weeks → ≈ 70,000 participants

Could be largest prospective, interventional clinical study ever done in a short time frame!

Documents